Menopause and Sleep Apnea: The Diagnosis Most Women Miss

Yes, and the effect is larger than most women realize. The Wisconsin Sleep Cohort Study, one of the longest-running sleep research programs in the world, measured breathing during sleep in hundreds of middle-aged women and compared them by menopausal status. After adjusting for age, body size, smoking and other confounders, postmenopausal women had an odds ratio of 2.6 for having five or more apnea or hypopnea events per hour, and 3.5 for fifteen or more events per hour, the threshold for moderate-to-severe disease (Young et al., AJRCCM 2003).

The critical part of that finding is the phrase "after adjusting for body habitus." It would be easy to assume this is simply a weight story, since midlife weight gain is common. But the increased risk persisted independently of body size. Something about the hormonal transition itself changes how women breathe at night.

The type of menopause matters too. A pooled analysis published in the American Journal of Epidemiology found a 27% higher hazard of developing OSA after surgical menopause (hysterectomy with oophorectomy) compared with natural menopause. Losing ovarian hormones abruptly appears to be harder on the airway than losing them gradually.

Before menopause, sleep apnea is roughly two to three times more common in men. After menopause, that gap narrows dramatically. Yet referral patterns have not caught up, which is the core of the problem this article is about.

Three mechanisms are at work, and they compound each other.

First, progesterone is a respiratory stimulant. It increases the drive to breathe and helps maintain tone in the muscles of the upper airway, particularly the genioglossus, the muscle that keeps your tongue from falling backward when you lie down. As progesterone falls in perimenopause and effectively disappears afterward, that protective drive weakens.

Second, estrogen influences soft-tissue structure and inflammation in the upper airway. Declining estrogen is associated with changes in mucosal tissue and increased collapsibility of the pharynx during sleep.

Third, fat redistribution. The menopause transition shifts fat storage from hips and thighs toward the abdomen and, importantly, the neck and tongue. Fat deposition around the airway is one of the strongest structural predictors of obstructive sleep apnea, and it can happen without a large change on the scale. This is the same visceral redistribution described in our piece on [why belly fat shifts in menopause](/blog/glp1-menopause-visceral-fat-why-belly-fat-shifts).

Sleep fragmentation from night sweats adds a fourth layer. Repeated awakenings destabilize breathing control and make apneas more likely in the lighter sleep that follows. If night sweats are part of your picture, our guide to [stopping menopause night sweats](/blog/menopause-night-sweats-causes-and-how-to-stop-them) is worth reading alongside this one.

Because the textbook picture was built from men. The stereotype is a heavyset man who snores thunderously, stops breathing in ways his partner notices, and falls asleep at his desk. Women with the same underlying condition frequently present differently.

The most common presentations in women are insomnia (particularly waking at 3 or 4 a.m. and struggling to get back to sleep), unrefreshing sleep, daytime fatigue rather than overt sleepiness, morning headaches, anxiety or low mood, and nocturia, the need to urinate two or more times a night. Snoring may be present but softer, and many women sleep alone or have partners who do not report it.

Every one of those symptoms is also a well-documented menopause symptom. So the pattern-matching goes: 52-year-old woman, tired, anxious, waking at 3 a.m., must be perimenopause. That is often correct. But it means the women whose symptoms come from an airway problem get treated for something else, sometimes for years.

The cost of missing it is not just tiredness. Untreated OSA raises blood pressure, worsens insulin resistance, increases atrial fibrillation risk and contributes to cardiovascular disease, all of which are already rising in midlife as described in [why blood pressure rises in menopause](/blog/menopause-blood-pressure-why-it-rises-and-what-helps).

In SWAN, 34.3% of perimenopausal women reported sleep disturbance compared with 28.0% of premenopausal women. Most of that is genuine hormonal insomnia. But a meaningful minority is undiagnosed apnea hiding inside those numbers.

Any one of these on its own is not diagnostic. Two or three together justify asking.

Waking with a headache most mornings, especially a dull frontal headache that fades within an hour or two of getting up. This reflects overnight carbon dioxide retention and is one of the more specific signals.

Waking up gasping, choking, or with your heart pounding. Many women interpret this as anxiety or a palpitation episode, and it can be, as covered in [why your heart races in menopause](/blog/menopause-heart-palpitations-why-your-heart-races-and-what-helps). But an apnea ending in an arousal produces exactly this sensation.

Getting eight hours and feeling like you got four. Sleep apnea fragments sleep architecture without necessarily waking you fully, so time in bed stops correlating with how you feel.

Needing to urinate two or more times a night without a bladder or prostate explanation. Apnea events raise cardiac filling pressures, which triggers a hormone that increases urine production.

High blood pressure that is hard to control, particularly if it requires three or more medications, or blood pressure that does not dip at night.

Any reported snoring, gasping, or breathing pauses from a partner, however occasional.

If persistent fatigue is your dominant symptom, it is worth ruling out the other common midlife causes too, which our guide to [menopause fatigue](/blog/menopause-fatigue-why-youre-exhausted-and-what-helps) covers, including thyroid problems and iron deficiency.

Diagnosis is far easier than it used to be. Home sleep apnea testing is now standard for most people with suspected uncomplicated OSA. You wear a small device with a finger sensor and a chest or nasal sensor for one to three nights in your own bed. An in-lab polysomnogram is still used when the picture is complicated, when central sleep apnea is suspected, or when a home test comes back negative but suspicion remains high.

A caution: screening questionnaires such as STOP-BANG were validated largely in male populations and give points for male sex and neck circumference. A woman can have significant OSA and score low. A low questionnaire score should not close the door if symptoms fit.

CPAP remains the most effective treatment and works by splinting the airway open with gentle air pressure. Modern machines are quiet, and mask options have expanded considerably, including small nasal pillow designs. Adherence is the main challenge, and it improves substantially with proper mask fitting and a few weeks of adjustment.

Mandibular advancement devices, custom oral appliances that hold the lower jaw slightly forward, are a reasonable alternative for mild to moderate disease or for people who cannot tolerate CPAP.

Positional therapy helps the subset of people whose apneas occur almost entirely on their back. Weight loss meaningfully reduces severity when excess weight is a contributor.

On that last point, tirzepatide reduced apnea events by roughly 25 to 29 per hour in the SURMOUNT-OSA trials (NEJM, 2024), a large effect that led to a specific FDA indication. Our explainer on [GLP-1s, sleep apnea and menopause](/blog/glp1-sleep-apnea-menopause-surmount-osa-what-it-means) covers what that means in practice.

Hormone therapy is not a treatment for sleep apnea. Observational studies suggest lower OSA prevalence among HRT users, but it has never been shown in a trial to treat the condition, and it should not replace testing.

That is a common and useful outcome. A negative sleep study rules out a serious, treatable condition and redirects attention to the actual cause, which in midlife is usually a combination of hormonal sleep fragmentation, vasomotor symptoms and anxiety.

For hormonally driven insomnia, the interventions with the best evidence are CBT-I (cognitive behavioral therapy for insomnia), which outperforms sleep medication for long-term outcomes and is recommended as first-line treatment by major sleep bodies, and treatment of the vasomotor symptoms themselves, whether with hormone therapy or a non-hormonal option. Our guide to [menopause insomnia](/blog/menopause-insomnia-why-you-cant-sleep-and-what-helps) covers the full toolkit.

A few environmental changes genuinely help: keeping the bedroom at 16 to 18°C, moisture-wicking bedding, avoiding alcohol within three hours of bed (alcohol both worsens night sweats and relaxes airway muscles), and consistent wake times including on weekends.

It is also worth checking iron and ferritin if you are still cycling, and thyroid function, because both mimic this symptom cluster closely.

The broader point stands regardless of your result. Midlife sleep complaints in women are too often absorbed into a general "it's the change" explanation, and something specific and fixable gets missed. Asking for a test is not overreacting. It is the single most useful thing you can do with a year of unexplained exhaustion.